Funding Opportunities

Looking to highlight a funding opportunity? Please send a brief description, link, and deadline to communications@massbio.org

State & Federal Programs

 

NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer  (SBTT) Grants

 

Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (PAR-13-327)

The National Cancer Institute (NCI) announces the availability of a funding opportunity aimed at accelerating the development and commercialization of highly innovative technologies that improve molecular and/or cellular analysis of cancer with a significant likelihood for either overcoming persistent challenges or obstacles or opening entirely new fields for cancer research or clinical care. This Program Announcement complements the goals of the NCI's Innovative Molecular Analysis Technologies (IMAT) program by facilitating a path towards technology commercialization. Prior participation in the IMAT Program is not required for eligibility for this FOA. Applications are expected to indicate the significant attributes and advantages of the proposed technology over currently available technologies and conventional approaches. Click here to learn more.

Receipt Dates: May 28, 2014; November 4, 2014; May 27, 2015; November 4, 2015; May 27, 2016

 

Additional Opportunities

 

Janssen Labs @LabCentral Challenge: Win A Year of Lab Space

 Deadline: May 8th, 2014

In honor of the Grand Opening of LabCentral and the one-year anniversary of the opening of its Boston Innovation Center, Johnson & Johnson Innovation has launched a quick fire challenge to award three companies $50,000 each to become a part of the Janssen Labs @LabCentral community for one year, starting June 1, 2014.

The winners will not only benefit from world-class lab facilities, but they will also receive access to expert mentoring and regular community building events.

To join the challenge, simply send a description of your company, a list of team members, any sources of funding, and your contact information to Kara Bortone at kbortone@its.jnj.com.

 

The Michael J. Fox Foundation Rapid Response Innovation Awards

Deadline: No deadline; applications accepted anytime

One-year grants to jump start new ideas in PD research. The Rapid Response Innovation Awards (RRIA) program supports high-risk, high-reward projects with little-to-no existing preliminary data, but with potential to significantly impact our understanding of Parkinson’s disease.  Moreover, this program is well-suited for early exploratory studies that may open the field up to new targets or pathways that may ultimately feed the early drug development pipeline for a treatment of PD.

 

Delivering Scientific Innovation for Autism LLC (DELSIA) Product Development Funding

There is no deadline to apply; submit an Expressions of Interest here.

DELSIAis an independent nonprofit venture philanthropy affiliate of the autism research and advocacy foundation Autism Speaks. DELSIA provides funds to for-profit partners to advance the development of products that address unmet medical and behavioral health needs of the autism community. It was created as an innovative funding vehicle with the goal of improving outcomes for individuals with autism spectrum disorder (ASD). DELSIA aims to do this by ensuring that scientific breakthroughs and technological advances are developed into products that improve health and quality of life for individuals with autism and their families. Our purpose is to transform lives by serving as a catalyst to facilitate and accelerate the delivery and availability of impactful products.

EvaluatePharma